Classifications

• • C—CHEMISTRY; METALLURGY
  • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
  • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
  • C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
  • C11D17/0047—Detergents in the form of bars or tablets
  • C11D17/0065—Solid detergents containing builders
  • C11D17/0073—Tablets
  • C11D17/0078—Multilayered tablets

Definitions

• the present invention relates to a laundry or automatic dishwashing composition in the tablet form, comprising a pectate lyase.
• detergent compositions include nowadays a complex combination of active ingredients which fulfill certain specific needs.
• current detergent formulations generally include detergent enzymes providing cleaning and fabric care benefits.
• stains stemming from plants, wood, mould-clay based soils, muddy soils, and fruits is one of today's toughest cleaning task; especially with the trend toward low wash temperatures.
• These stains typically contain complex mixtures of fibrous material based mainly on carbohydrates and their derivatives : fibres and cell wall components.
• Plant based soils are additionally accompanied with amylose, sugars and their derivatives.
• Food soils are often difficult to remove effectively from a soiled substrate.
• Highly coloured or "dried-on" soils derived from fruit and/or vegetable juices are particularly challenging to remove. Specific examples of such soils would include orange juice, tomato juice, banana, mango or broccoli soils.
• pectin polymers are important constituents of plant cell walls.
• Pectin is a hetero-polysaccharide with a backbone composed of alternating homogalacturonan (smooth regions) and rhamnogalacturonan (hairy regions).
• the smooth regions are linear polymers of 1 ,4-linked alpha-D-galacturonic acid.
• the galacturonic acid residues can be methyl-esterified on the carboxyl group to a varying degree, usually in a non-random fashion with blocks of polygalacturonic acid being completely methyl-esterified.
• the substrates on which pectin containing stains are commonly found can be fabrics, dishware or hard surfaces.
• pectin degrading enzymes are known to provide soil/stain removal benefits when used in washing and cleaning operations, specifically to provide the removal of a broad range of plant, dirt, and fruit based stains and enhance the body soil cleaning profile of the detergent compositions.
• pectin degrading enzyme it is meant herein any enzyme which acts to break down pectin substances and pectin related substances.
• Pectin degrading enzymes can be classified according to their preferential substrate, highly methyl-esterified pectin or low methyl-esterified pectin and polygalacturonic acid (pectate), and their reaction mechanism, beta-elimination or hydrolysis.
• Pectin degrading enzymes can be mainly endo-acting, cutting the polymer at random sites within the chain to give a mixture of oligomers, or they may be exo-acting, attacking from one end of the polymer and producing monomers or dimers.
• pectinase activities acting on the smooth regions of pectin are included in the classification of enzymes provided by the Enzyme Nomenclature (1992) such as pectate lyase (EC 4.2.2.2), pectin lyase (EC 4.2.2.10), polygalacturonase (EC 3.2.1.15), exo- polygalacturonase (EC 3.2.1.67), exo-polygalacturonate lyase (EC 4.2.2.9) and exo-poly-alpha-galacturonosidase (EC 3.2.1.82).
• the pectin degrading enzymes are natural mixtures of the above mentioned enzymatic activities.
• pectin degrading enzyme has a unique profile of substrate specificity, activity and stability under different hardness, pH, temperature, surfactant and other detergent ingredient matrix conditions.
• Pectin degrading enzymes are specifically directed to degrade pectin substances and in particular plant cell walls.
• pectate lyase enzymes are directed to the cleavage of ⁇ -D-(1 ,4) glycosidic bonds in poly-D-galacturonans by the mechanism of ⁇ - elimination. It is recognised in the art that many pectate lyases are metal ion dependent, in particular Calcium dependent. Therefore, such enzymes may be unstable in a detergent matrix and may lose their activity when calcium is sequestered by builders also present in the detergent matrix.
• the cleaning benefits of pectate lyase enzymes can be optimised and maximised with a time controlled release technology.
• the time controlled technology is a tablet wherein the pectate lyase is separated from the inhibiting / deactivating other detergent ingredients in a different product phase having a different solubility in the wash. It has been surprisingly found that optimal performance efficiency of the pectate lyase enzyme can be achieved when said enzyme is incorporated into a tablet and such system delivers significant soil and stain cleaning benefits. It has further been found that such time controlled release technology allows a broader range of Pectate Lyases to be used, including those that show a high degree of instability in standard detergent matrices.
• detergent compositions in tablet form are known in the art. It is understood that detergent compositions in tablet form hold several advantages over detergent compositions in particulate form, such as ease of dosing, handling, transportation and storage.
• Detergent tablets are most commonly prepared by pre-mixing components of a detergent composition and forming the pre-mixed detergent components into a tablet using any suitable equipment, preferably a tablet press. Tablets are typically formed by compression of the components of the detergent composition so that the tablets produced are sufficiently robust to be able to withstand handling and transportation without sustaining damage. In addition to being robust, tablets must also dissolve sufficiently fast so that the detergent components are released into the wash water as soon as possible at the beginning of the wash cycle. Prior art already tackled the problem of finding a balance between tablet robustness and tablet dissolution.
• Multi-phase detergent tablets described in the prior art are prepared by compressing a first composition in a tablet press to form a substantially planar first layer. A further detergent composition is then delivered to the tablet press on top of the first layer. This second composition is then compressed to form another substantially planar second layer. Other multi-phase tablets exhibiting differential dissolution are prepared such that the second layer is compressed at a lower force than the first layer resulting in faster dissolution of the second layer.
• pectin degrading enzymes in detergents has already been recognised in the art.
• the use of pectin degrading enzyme is also recognised for the cleaning of contact lenses (US 4,710,313 - J60196724).
• Enzymes having a pectinase activity are described in DE 36 35 427 to increase the capacity of the detergent for removing inorganic dirt, e.g. sludges, from laundry without damaging the fibres and without discoloration to allow the use of zeolites and polycarbonate builders which have a lower capacity for dispersing inorganic materials than the phosphates.
• JP 60226599 describes detergent compositions comprising conventional detergent actives and a cellulase and hydrolase such as hemicellulase, pectinase, amylase or protease.
• a cellulase and hydrolase such as hemicellulase, pectinase, amylase or protease.
• the combination of cellulase and hydrolase is said to give a good washing effect on inorganic fouling together with enzymatic activity.
• WO95/09909 describes an enzyme preparation comprising modified enzymes selected from the group of amylase, lipase, oxidoreductase, pectinase or hemicellulase; the modified enzymes having an improved performance due to an alkaline pi and/or increased surface activity obtained by chemical modification or amino acid substitution.
• Modified pectin and/or pectolytic and/or hemi-cellulolytic and /or lipolytic enzymes are applied advantageously in the papermaking industry and modified amylase and/or lipase in laundry and dishwashing.
• Pectate lyases have been cloned from different bacterial genera such as Erwinia, Pseudomonas, Klebsiella and Xanthomonas, Streptomyces, Penicillium, Baceriodes, Thermomonospora, Fusarium, and Aspergillus. Also from Bacillus subtilis (Nasser et al. (1993) FEBS 335:319-326) and Bacillus sp. YA-14 (Kim et al. (1994) Biosci. Biotech. Biochem. 58:947-949) cloning of a pectate lyase has been described.
• the present invention relates to laundry or automatic dishwashing compositions in the tablet form, comprising a pectate lyase for improved cleaning performance, especially on plant-based and body soils.
• the detergent tablet of the present invention is not only sufficiently robust to withstand handling and transportation, but also at least a portion of which dissolves rapidly in the wash water providing rapid delivery of the pectate lyase enzyme.
• At least one phase of the tablet dissolves in the wash water within the first ten minutes, preferably five minutes, more preferably four minutes of the wash cycle of an automatic dishwashing or laundry washing machine.
• the washing machine is either an automatic dishwashing or laundry washing machine.
• the time within which the multi-phase tablet or a phase thereof or a detergent active component dissolves is determined according to DIN 44990 using a dishwashing machine available from Bosch on the normal 65°C washing program with water hardness at 18°H using a minimum of six replicates or a sufficient number to ensure reproducibility.
• the pectate lyase and buffer materials are incorporated into the rapid dissolving portion of the tablet.
• the pectate lyase is released earlier than the inhibiting / deactivating other detergent ingredients and that optimum pectate lyase activity is obtained at the beginning of the wash under buffered conditions, allowing the formulation in detergent of pectate lyases in the full range of available pectate lyases.
• a tablet which comprises a section 1 and a section 2 wherein the section 2 comprises a higher level of pectate lyase.
• slow dissolving it is meant herein a tablet dissolving in more than 10 minutes according to the DIN 44990 method described.
• rapid dissolving it is meant herein a tablet dissolving within the first ten minutes, preferably five minutes, more preferably four minutes according to the DIN 44990 method described above.
• Suitable for the purpose of the present invention are the single and multi-phase detergent tablets for use in automatic dishwashing and laundry, having improved strength, especially on long term storage and excellent dissolution characteristics as described in the co-pending European Application No. 9818716.4 filed 28 August 1998.
• Such detergent tablet is not only sufficiently robust to withstand handling and transportation, but also at least a portion of which dissolves rapidly in the wash water providing rapid delivery of the pectate lyase enzyme and buffer materials. It is preferred that at least one phase, preferably section 2, of the tablet dissolves in the wash water within the first ten minutes, preferably five minutes, more preferably four minutes of the wash cycle of an automatic dishwashing or laundry washing machine according to DIN 44990, above.
• the detergent tablets of the present invention comprise a first phase and, in multi-phase tablet embodiments, also comprise a second and optional subsequent phases.
• the first phase is in the form of a shaped body of detergent composition comprising one or more detergent components as described below.
• Preferred detergent components of the first phase include other builder components, bleach, enzymes and surfactant.
• the components of the detergent composition are mixed together by, for example admixing dry components or spraying-on liquid components. The components are then formed into a first phase using any suitable compression equipment, but preferably in a tablet press.
• the first phase is prepared such that it comprises at least one mould in the surface of the shaped body.
• the mould is created using a specially designed tablet press wherein the surface of the punch that contacts the detergent composition is shaped such that when it contacts and presses the detergent composition it presses a mould, or multiple moulds into the first phase of the multi-phase detergent tablet.
• the mould will have an inwardly concave or generally concave surface to provide improved adhesion to the second phase.
• the tablets of the invention can also include one or more additional phases prepared from a composition or compositions which comprise one or more detergent components as described below.
• At least one phase (herein referred to as a second phase) preferably takes the form of a particulate solid (which term encompasses powders, granules, agglomerates, and other particulate solids including mixtures thereof with liquid binders, meltable solids, spray-ons, etc) compressed either as a layer or into/within the one or more moulds of the first phase of the detergent tablet such that the second phase itself takes the form of a shaped body.
• Preferred detergent components include builders, colourants, binders, surfactants, disrupting agents and enzymes, in particular Pectate Lyase enzymes.
• the second and optional subsequent phases comprise a disrupting agent that may be selected from either a disintegrating agent or an effervescent agent.
• Suitable disintegrating agents include agents that swell on contact with water or facilitate water influx and/or efflux by forming channels in the detergent tablet. Any known disintegrating or effervescing agent suitable for use in laundry or dishwashing applications is envisaged for use herein.
• Suitable disintegrating agent include starch, starch derivatives such as Arbocel (tradename), Vivapur (tradename) both available from Rettenmaier, Nymcel (tradename) available from Metsa-serla , alginates, acetate trihydrate, burkeite, monohydrated carbonate formula Na 2 CO 3 .H 2 O, carboxymethylcellulose (CMC), CMC-based polymers, sodium acetate, aluminium oxide.
• Suitable effervescing agents are those that produce a gas on contact with water. Suitable effervescing agents may be oxygen, nitrogen dioxide or carbon dioxide evolving species.
• Examples of preferred effervescent agents may be selected from the group consisting of perborate, percarbonate, carbonate, bicarbonate in combination with inorganic acids such as sulphamic acid and/or carboxylic acids such as citric, malic and maleic acid and mixtures thereof.
• the components of the detergent composition are mixed together by for example premixing dry components and admixing, preferably by spray-on, liquid components.
• the components of the second and optional subsequent phases are then compressed to form one or more layers or are fed into and retained within the mould provided by the first phase.
• the preferred mould embodiments of the present invention comprises two phases; a first and a second phase.
• the first phase will normally comprise one mould and the second phase will normally consist of a single detergent active composition.
• the first phase may comprise more than one mould and the second phase may be prepared from more than one detergent active composition.
• the second phase may comprise more than one detergent active composition contained within one mould. It is also envisaged that several detergent active compositions are contained in separate moulds. In this way potentially chemically sensitive detergent components can be separated in order to avoid any loss in performance caused by components reacting together and potentially becoming inactive or exhausted.
• the first, second and/or optional subsequent phases may comprise a binder.
• the binder is selected from the group consisting of organic polymers, for example polyethylene and/or polypropylene glycols having an average molecular weight of from about 1000 to about 12000, especially those of molecular weight 4000, 6000 and 9000, polyvinyi pyrolindone (PVP), especially PVP of molecular weight 90 000, polyacrylates, sugars and sugar derivatives, starch and starch derivatives, for example hydroxy propyl methyl cellulose (HPMC) and carboxy methyl cellulose (CMC); and inorganic polymers, such as hexametaphosphate.
• PVP polyvinyi pyrolindone
• HPMC hydroxy propyl methyl cellulose
• CMC carboxy methyl cellulose
• inorganic polymers such as hexametaphosphate.
• the polyethyleneglycol binders are highly preferred herein.
• the first phase constitutes at least 50% of the total tablet weight. More preferably the first phase comprises from 60 to 90%, even more preferably from 70 to 85% and most preferably from 80 to 85% of the total tablet weight.
• the second and optional subsequent phases comprise less than 40% of the tablet weight. More preferably the second and/or optional subsequent phases comprise between 20 and 30%, most preferably from 8 to 15% of the total tablet weight
• the detergent tablets are prepared using any suitable tabletting equipment.
• multi-phase tablets herein are prepared by compression in a tablet press capable of preparing a tablet comprising a mould.
• the first phase is prepared using a specially designed tablet press.
• the punch(es) of this tablet press are modified so that the surface of the punch that contacts the detergent composition has a convex surface.
• a first detergent composition is delivered into the die of the tablet press and the punch is lowered to contact and then compress the detergent composition to form a first phase.
• the first detergent composition is compressed using an applied pressure of at least 250 kg/cm 2 , preferably between 350 and 2000 kg/cm 2 , more preferably 500 to 1500 kg/cm 2 , most preferably 600 to 1200 kg/cm 2 .
• the punch is then elevated, exposing the first phase containing a mould.
• a second and optionally a subsequent detergent composition(s) comprising the pectate lyase is then delivered into the mould.
• the specially designed tablet press punch is then lowered a second time to lightly compress the second and optional subsequent detergent composition(s) to form the second and optional subsequent phase(s).
• the optional subsequent phase is prepared in a subsequent compression step substantially similar to the second compression step described above.
• the second and optional subsequent detergent composition(s) is compressed at a pressure of preferably less than 350 kg/cm 2 , more preferably from 40 to 300 kg/cm 2 , most preferably from 70 to 270 kg/cm 2 .
• the punch is elevated a second time and the multi-phase detergent tablet is ejected from the tablet press.
• Single and multi-layer tablets without moulds can be prepared in a similar manner except using a tablet punch having a planar surface.
• the detergent tablets of the invention are prepared by compression of one or more compositions comprising detergent active components.
• the compositions may include a variety of different detergent components including builder compounds, surfactants, enzymes, bleaching agents, alkalinity sources, colourants, perfume, lime soap dispersants, organic polymeric compounds including polymeric dye transfer inhibiting agents, crystal growth inhibitors, heavy metal ion sequestrants, metal ion salts, enzyme stabilisers, corrosion inhibitors, suds suppressers, solvents, fabric softening agents, optical brighteners and hydrotropes.
• the proportions of these active components are given by weight of the corresponding composition of active detergent components, unless specified otherwise.
• highly preferred detergent components of the first rapid dissolving phase include builder, enzymes specifically the pectate lyase, buffering agent and disrupting agent.
• Highly preferred detergent components of the second slower dissolving phase include a builder compound, a surfactant, an enzyme and a bleaching agent.
• Detergent builders can optionally be included in the compositions herein to assist in controlling mineral hardness. Inorganic as well as organic builders can be used. Builders are typically used in fabric laundering compositions to assist in the removal of particulate soils.
• Inorganic or P-containing detergent builders include, but are not limited to, the alkali metal, ammonium and alkanolammonium salts of polyphosphates (exemplified by the tripolyphosphates, pyrophosphates, and glassy polymeric meta-phosphates), phosphonates, phytic acid, silicates, carbonates (including bicarbonates and sesquicarbonates), sulphates, and aluminosilicates.
• non-phosphate builders are required in some locales.
• compositions herein function surprisingly well even in the presence of the so-called “weak” builders (as compared with phosphates) such as citrate, or in the so-called “underbuilt” situation that may occur with zeolite or layered silicate builders.
• silicate builders are the alkali metal silicates, particularly those having a Si ⁇ 2".Na2 ⁇ ratio in the range 1.6:1 to 3.2:1 and layered silicates, such as the layered sodium silicates described in U.S. Patent 4,664,839, issued May 12, 1987 to H. P. Rieck.
• NaSKS-6 is the trademark for a crystalline layered silicate marketed by Hoechst (commonly abbreviated herein as "SKS-6").
• Hoechst commonly abbreviated herein as "SKS-6”
• the Na SKS-6 silicate builder does not contain aluminum.
• NaSKS-6 has the delta-Na2Si ⁇ 5 morphology form of layered silicate.
• SKS-6 is a highly preferred layered silicate for use herein, but other such layered silicates, such as those having the general formula NaMSi x ⁇ 2 ⁇ + ⁇ yH2 ⁇ wherein M is sodium or hydrogen, x is a number from 1.9 to 4, preferably 2, and y is a number from 0 to 20, preferably 0 can be used herein.
• Various other layered silicates from Hoechst include NaSKS-5, NaSKS-7 and NaSKS-11 , as the alpha, beta and gamma forms.
• delta- Na2SiO5 NaSKS-6 form
• Other silicates may also be useful such as for example magnesium silicate, which can serve as a crispening agent in granular formulations, as a stabilizing agent for oxygen bleaches, and as a component of suds control systems.
• magnesium silicate which can serve as a crispening agent in granular formulations, as a stabilizing agent for oxygen bleaches, and as a component of suds control systems.
• Examples of carbonate builders are the alkaline earth and alkali metal carbonates as disclosed in German Patent Application No. 2,321 ,001 published on November 15, 1973.
• Aluminosilicate builders are useful in the present invention. Aluminosilicate builders are of great importance in most currently marketed heavy duty granular detergent compositions, and can also be a significant builder ingredient in liquid detergent formulations. Aluminosilicate builders include those having the empirical formula:
• z and y are integers of at least 6, the molar ratio of z to y is in the range from 1.0 to about 0.5, and x is an integer from about 15 to about 264.
• aluminosilicate ion exchange materials are commercially available. These aluminosilicates can be crystalline or amorphous in structure and can be naturally-occurring aluminosilicates or synthetically derived. A method for producing aluminosilicate ion exchange materials is disclosed in U.S. Patent
• crystalline aluminosilicate ion exchange material useful herein are available under the designations Zeolite A, Zeolite P (B), Zeolite MAP and Zeolite X.
• the crystalline aluminosilicate ion exchange material has the formula:
• This material is known as Zeolite A.
• the aluminosilicate has a particle size of about 0.1-10 microns in diameter.
• Organic detergent builders suitable for the purposes of the present invention include, but are not restricted to, a wide variety of polycarboxylate compounds.
• polycarboxylate refers to compounds having a plurality of carboxylate groups, preferably at least 3 carboxylates.
• Polycarboxylate builder can generally be added to the composition in acid form, but can also be added in the form of a neutralized salt. When utilized in salt form, alkali metals, such as sodium, potassium, and lithium, or alkanolammonium salts are preferred.
• alkali metals such as sodium, potassium, and lithium, or alkanolammonium salts are preferred.
• Included among the polycarboxylate builders are a variety of categories of useful materials.
• One important category of polycarboxylate builders encompasses the ether polycarboxylates, including oxydisuccinate, as disclosed in Berg, U.S. Patent 3,128,287, issued April 7, 1964, and Lamberti et al, U.S.
• Patent 3,635,830 issued January 18, 1972. See also "TMS/TDS" builders of U.S. Patent 4,663,071 , issued to Bush et al, on May 5, 1987.
• Suitable ether polycarboxylates also include cyclic compounds, particularly alicyclic compounds, such as those described in U.S. Patents 3,923,679; 3,835,163; 4,158,635; 4,120,874 and 4,102,903.
• ether hydroxypolycarboxylates copolymers of maleic anhydride with ethylene or vinyl methyl ether, 1 , 3, 5- trihydroxy benzene-2, 4, 6-trisulphonic acid, and carboxymethyloxysuccinic acid
• various alkali metal, ammonium and substituted ammonium salts of polyacetic acids such as ethylenediamine tetraacetic acid and nitrilotriacetic acid
• polycarboxylates such as mellitic acid, succinic acid, oxydisuccinic acid, polymaleic acid, benzene 1 ,3,5-tricarboxylic acid, carboxymethyloxysuccinic acid, and soluble salts thereof.
• Citrate builders e.g., citric acid and soluble salts thereof (particularly sodium salt), are polycarboxylate builders of particular importance for heavy duty liquid detergent formulations due to their availability from renewable resources and their biodegradability. Citrates can also be used in granular compositions, especially in combination with zeolite and/or layered silicate builders. Oxydisuccinates are also especially useful in such compositions and combinations.
• succinic acid builders include the C5-C20 alkyl and alkenyl succinic acids and salts thereof.
• a particularly preferred compound of this type is dodecenylsuccinic acid.
• succinate builders include: laurylsuccinate, myristylsuccinate, palmitylsuccinate, 2-dodecenylsuccinate (preferred), 2-pentadecenylsuccinate, and the like. Laurylsuccinates are the preferred builders of this group, and are described in European Patent Application 86200690.5/0,200,263, published November 5, 1986.
• the various alkali metal phosphates such as the well-known sodium tripolyphosphates, sodium pyrophosphate and sodium orthophosphate can be used.
• Phosphonate builders such as ethane-1-hydroxy-1 ,1-diphosphonate and other known phosphonates (see, for example, U.S. Patents 3,159,581 ; 3,213,030; 3,422,021 ; 3,400,148 and 3,422,137) can also be used.
• Surfactants suitable herein include anionic surfactants such as alkyl sulfates, alkyl ether sulfates, alkyl benzene sulfonates, alkyl glyceryl sulfonates, alkyl and alkenyl sulphonates, alkyl ethoxy carboxylates, N-acyl sarcosinates, N-acyl taurates and alkyl succinates and sulfosuccinates, wherein the alkyl, alkenyl or acyl moiety is C5-C20 > preferably C ⁇ Q-CI S linear or branched; cationic surfactants such as choline esters (US-A-4228042, US-A-4239660 and US-A- 4260529) and mono C6-C-16 N-alkyl or alkenyl ammonium surfactants wherein the remaining N positions are substituted by methyl, hydroxyethyl or hydroxypropyl groups; low and
• Surfactants suitable herein are disclosed, for example, in US-A-3, 929,678 , US- A- 4,259,217, EP-A-0414 549, WO-A-93/08876 and WO-A-93/08874.
• Surfactants are typically present at a level of from about 0.2% to about 30% by weight, more preferably from about 0.5% to about 10% by weight, most preferably from about 1% to about 5% by weight of composition.
• Enzymes suitable for use in section 1 herein include enzymes like protease, amylase, lipase, cutinase and/or cellulase.
• Suitable proteases are the subtilisins which are obtained from particular strains of B. subtilis and ⁇ . licheniformis (subtilisin BPN and BPN').
• One suitable protease is obtained from a strain of Bacillus, having maximum activity throughout the pH range of 8-12, developed and sold as ESPERASE® by Novo Industries A/S of Denmark, hereinafter "Novo". The preparation of this enzyme and analogous enzymes is described in GB 1 ,243,784 to Novo.
• Other suitable proteases include ALCALASE®, DURAZYM® and SAVINASE® from Novo and MAXATASE®, MAXACAL®, PROPERASE® and MAXAPEM® (protein engineered Maxacal) from Gist-Brocades.
• Proteolytic enzymes also encompass modified bacterial serine proteases, such as those described in European Patent Application Serial Number 87 303761.8, filed April 28, 1987 (particularly pages 17, 24 and 98), and which is called herein "Protease B", and in European Patent Application 199,404, Venegas, published October 29, 1986, which refers to a modified bacterial serine protealytic enzyme which is called "Protease A” herein.
• Protease C is a variant of an alkaline serine protease from Bacillus in which lysine replaced arginine at position 27, tyrosine replaced valine at position 104, serine replaced asparagine at position 123, and alanine replaced threonine at position 274.
• Protease C is described in EP 90915958:4, corresponding to WO 91/06637, Published May 16, 1991. Genetically modified variants, particularly of Protease C, are also included herein.
• a preferred protease referred to as "Protease D” is a carbonyl hydrolase variant having an amino acid sequence not found in nature, which is derived from a precursor carbonyl hydrolase by substituting a different amino acid for a plurality of amino acid residues at a position in said carbonyl hydrolase equivalent to position +76, preferably also in combination with one or more amino acid residue positions equivalent to those selected from the group consisting of +99, +101 , +103, +104, +107, +123, +27, +105, +109, +126, +128, +135, +156, +166, +195, +197, +204, +206, +210, +216, +217, +218, +222, +260, +265, and/or +274 according to the numbering of Bacillus amyloliquefaciens subtilisin, as described in WO95/10591 and in the patent application of C.
• a carbonyl hydrolase variant of the protease described in WO95/10591 having an amino acid sequence derived by replacement of a plurality of amino acid residues replaced in the precursor enzyme corresponding to position +210 in combination with one or more of the following residues : +33, +62, +67, +76, +100, +101 , +103, +104, +107, +128, +129, +130, +132, +135, +156, +158, +164, +166, +167, +170, +209, +215, +217, +218, and +222, where the numbered position corresponds to naturally- occurring subtilisin from Bacillus amyloliquefaciens or to equivalent amino acid residues in other carbonyl hydrolases or subtilisins, such as Bacillus lentus subtilisin
• proteases described in patent applications EP 251 446 and WO 91/06637, protease BLAP® described in WO91/02792 and their variants described in WO 95/23221. See also a high pH protease from Bacillus sp. NCIMB 40338 described in WO 93/18140 A to Novo. Enzymatic detergents comprising protease, one or more other enzymes, and a reversible protease inhibitor are described in WO 92/03529 A to Novo. When desired, a protease having decreased adsorption and increased hydrolysis is available as described in WO 95/07791 to Procter & Gamble.
• a recombinant trypsin-like protease for detergents suitable herein is described in WO 94/25583 to Novo.
• Other suitable proteases are described in EP 516 200 by Unilever.
• the proteolytic enzymes are incorporated in the detergent compositions of the present invention a level of from 0.0001% to 2%, preferably from 0.001 % to 0.2%, more preferably from 0.005% to 0.1% pure enzyme by weight of the composition.
• the cellulases usable in the present invention include both bacterial or fungal cellulases. Preferably, they will have a pH optimum of between 5 and 12 and a specific activity above 50 CEVU/mg (Cellulose Viscosity Unit).
• Suitable cellulases are disclosed in U.S. Patent 4,435,307, Barbesgoard et al, J61078384 and WO96/02653 which discloses fungal cellulase produced respectively from Humicola insolens, Trichoderma, Thielavia and Sporotrichum.
• EP 739 982 describes cellulases isolated from novel Bacillus species. Suitable cellulases are also disclosed in GB-A-2.075.028; GB-A-2.095.275; DE-OS-2.247.832 and WO95/26398.
• cellulases examples include cellulases produced by a strain of Humicola insolens (Humicola grisea var. thermoidea), particularly the Humicola strain DSM 1800.
• Suitable cellulases are cellulases originated from Humicola insolens having a molecular weight of about 50KDa, an isoelectric point of 5.5 and containing 415 amino acids; and a " 43kD endoglucanase derived from Humicola insolens, DSM 1800, exhibiting cellulase activity; a preferred endoglucanase component has the amino acid sequence disclosed in PCT Patent Application No. WO 91/17243.
• suitable cellulases are the EGIII cellulases from Trichoderma longibrachiatum described in WO94/21801 , Genencor, published September 29, 1994. Especially suitable cellulases are the cellulases having color care benefits.
• cellulases examples include cellulases described in European patent application No. 91202879.2, filed November 6, 1991 (Novo). Carezyme and Celluzyme (Novo Nordisk A/S) are especially useful. See also WO91/17244 and WO91/21801. Other suitable cellulases for fabric care and/or cleaning properties are described in WO96/34092, WO96/17994 and WO95/24471. Said cellulases are normally incorporated in the detergent composition at levels from 0.0001% to 2% of pure enzyme by weight of the detergent composition.
• Peroxidase enzymes are used in combination with oxygen sources, e.g. percarbonate, perborate, persulfate, hydrogen peroxide, etc and with a phenolic substrate as bleach enhancing molecule. They are used for "solution bleaching", i.e. to prevent transfer of dyes or pigments removed from substrates during wash operations to other substrates in the wash solution.
• Peroxidase enzymes are known in the art, and include, for example, horseradish peroxidase, ligninase and haloperoxidase such as chloro- and bromo-peroxidase.
• Peroxidase-containing detergent compositions are disclosed, for example, in PCT International Application WO 89/099813, WO89/09813 and in European Patent application EP No. 91202882.6, filed on November 6, 1991 and EP No. 96870013.8, filed February 20, 1996. Also suitable is the laccase enzyme.
• Enhancers are generally comprised at a level of from 0.1% to 5% by weight of total composition.
• Preferred enhancers are substitued phenthiazine and phenoxasine 10-Phenothiazinepropionicacid (PPT), 10-ethylphenothiazine-4- carboxylic acid (EPC), 10-phenoxazinepropionic acid (POP) and 10- methylphenoxazine (described in WO 94/12621) and substitued syringates (C3- C5 substitued alkyl syringates) and phenols.
• Sodium percarbonate or perborate are preferred sources of hydrogen peroxide.
• Said peroxidases are normally incorporated in the detergent composition at levels from 0.0001% to 2% of pure enzyme by weight of the detergent composition.
• Suitable lipase enzymes for detergent usage include those produced by microorganisms of the Pseudomonas group, such as Pseudomonas stutzeri ATCC 19.154, as disclosed in British Patent 1 ,372,034.
• Suitable lipases include those which show a positive immunological cross-reaction with the antibody of the lipase, produced by the microorganism Pseudomonas fluorescent IAM 1057. This lipase is available from Amano Pharmaceutical Co. Ltd., Nagoya, Japan, under the trade name Lipase P "Amano,” hereinafter referred to as "Amano-P".
• lipases include Amano-CES, lipases ex Chromobacter viscosum, e.g. Chromobacter viscosum var. lipolyticum NRRLB 3673 from Toyo Jozo Co., Tagata, Japan; Chromobacter viscosum lipases from U.S. Biochemical Corp., U.S.A. and Disoynth Co., The Netherlands, and lipases ex Pseudomonas gladioli.
• lipases such as M1 Lipase ⁇ ap d LipomaxR (Gist-Brocades) and Lipolase ⁇ and Lipolase UltraR(Novo) which have found to be very effective when used in combination with the compositions of the present invention.
• lipolytic enzymes described in EP 258 068, WO 92/05249 and WO 95/22615 by Novo Nordisk and in WO 94/03578,
• cutinases [EC 3.1.1.50] which can be considered as a special kind of lipase, namely lipases which do not require interfacial activation. Addition of cutinases to detergent compositions have been described in e.g. WO-A-
• the lipases and/or cutinases are normally incorporated in the detergent composition at levels from 0.0001% to 2% of pure enzyme by weight of the detergent composition.
• Amylases can be included for removal of carbohydrate-based stains.
• WO94/02597 Novo Nordisk A/S published February 03, 1994, describes detergent compositions which incorporate mutant amylases. See also WO95/10603, Novo Nordisk A/S, published April 20, 1995.
• Other amylases known for use in detergent compositions include both ⁇ - and ⁇ -amylases.
• ⁇ - Amylases are known in the art and include those disclosed in US Pat. no. 5,003,257; EP 252,666; WO/91/00353; FR 2,676,456; EP 285,123; EP 525,610; EP 368,341; and British Patent specification no. 1 ,296,839 (Novo).
• amylases are stability-enhanced amylases described in WO94/18314, published August 18, 1994 and WO96/05295, Genencor, published February 22, 1996 and amylase variants having additional modification in the immediate parent available from Novo Nordisk A/S, disclosed in WO 95/10603, published April 95. Also suitable are amylases described in EP 277 216, WO95/26397 and WO96/23873 (all by Novo Nordisk).
• ⁇ -amylases examples are Purafect Ox Am® from Genencor and Termamyl®, Ban® .Fungamyl® and Duramyl®, all available from Novo Nordisk A/S Denmark.
• WO95/26397 describes other suitable amylases : ⁇ - amylases characterised by having a specific activity at least 25% higher than the specific activity of Termamyl® at a temperature range of 25°C to 55°C and at a pH value in the range of 8 to 10, measured by the Phadebas® ⁇ -amylase activity assay. Suitable are variants of the above enzymes, described in WO96/23873 (Novo Nordisk).
• amylolytic enzymes with improved properties with respect to the activity level and the combination of thermostability and a higher activity level are described in WO95/35382.
• the amylolytic enzymes are incorporated in the detergent compositions of the present invention a level of from 0.0001% to 2%, preferably from 0.00018% to 0.06%, more preferably from 0.00024% to 0.048% pure enzyme by weight of the composition.
• the above-mentioned enzymes may be of any suitable origin, such as vegetable, animal, bacterial, fungal and yeast origin. Origin can further be mesophilic or extremophilic (psychrophilic, psychrotrophic, thermophilic, barophilic, alkalophilic, acidophilic, halophilic, etc.). Purified or non-purified forms of these enzymes may be used.
• the variants may be designed such that the compatibility of the enzyme to commonly encountered ingredients of such compositions is increased.
• the variant may be designed such that the optimal pH, bleach or chelant stability, catalytic activity and the like, of the enzyme variant is tailored to suit the particular cleaning application.
• the isoelectric point of such enzymes may be modified by the substitution of some charged amino acids, e.g. an increase in isoelectric point may help to improve compatibility with anionic surfactants.
• the stability of the enzymes may be further enhanced by the creation of e.g. additional salt bridges and enforcing calcium binding sites to increase chelant stability. Special attention must be paid to the cellulases as most of the cellulases have separate binding domains (CBD). Properties of such enzymes can be altered by modifications in these domains.
• Said enzymes are normally incorporated in the detergent composition at levels from 0.0001% to 2% of pure enzyme by weight of the detergent composition.
• the enzymes can be added as separate single ingredients (prills, granulates, stabilized liquids, etc. containing one enzyme ) or as mixtures of two or more enzymes (e.g. cogranulates ).
• Other suitable detergent ingredients that can be added are enzyme oxidation scavengers which are described in co-pending European Patent application 92870018.6 filed on January 31 , 1992. Examples of such enzyme oxidation scavengers are ethoxylated tetraethylene polyamines.
• a range of enzyme materials and means for their incorporation into synthetic detergent compositions is also disclosed in WO 9307263 A and WO 9307260 A to Genencor International, WO 8908694 A to Novo, and U.S. 3,553,139, January 5, 1971 to McCarty et al. Enzymes are further disclosed in U.S. 4,101 ,457, Place et al, July 18, 1978, and in U.S. 4,507,219, Hughes, March 26, 1985. Enzyme materials useful for liquid detergent formulations, and their incorporation into such formulations, are disclosed in U.S. 4,261 ,868, Hora et al, April 14, 1981. Enzymes for use in detergents can be stabilised by various techniques.
• Enzyme stabilisation techniques are disclosed and exemplified in U.S. 3,600,319, August 17, 1971 , Gedge et al, EP 199,405 and EP 200,586, October 29, 1986, Venegas. Enzyme stabilisation systems are also described, for example, in U.S. 3,519,570. A useful Bacillus, sp.
• Bleaching agents suitable herein include chlorine and oxygen bleaches, especially inorganic perhydrate salts such as sodium perborate mono-and tetrahydrates and sodium percarbonate optionally coated to provide controlled rate of release (see, for example, GB-A-1466799 on sulfate/carbonate coatings), preformed organic peroxyacids and mixtures thereof with organic peroxyacid bleach precursors and/or transition metal-containing bleach catalysts (especially manganese or cobalt).
• Inorganic perhydrate salts are typically incorporated at levels in the range from about 1% to about 40% by weight, preferably from about 2% to about 30% by weight and more preferably from abut 5% to about 25% by weight of composition.
• Peroxyacid bleach precursors preferred for use herein include precursors of perbenzoic acid and substituted perbenzoic acid; cationic peroxyacid precursors; peracetic acid precursors such as TAED, sodium acetoxybenzene sulfonate and pentaacetylglucose; pernonanoic acid precursors such as sodium 3,5,5-trimethylhexanoyloxybenzene sulfonate (iso-NOBS) and sodium nonanoyloxybenzene sulfonate (NOBS); Phenolsulfonate ester of N- nonanoyl-6-aminocaproic acid (NACA-OBS, described in WO94/28106), which are perhydrolyzed to form a peracid as the active bleaching species, leading to improved bleaching effect, amide substituted alkyl peroxyacid precursors (EP-A- 0170386); and benzoxazin peroxyacid precursors (EP-A-03
• Bleach precursors are typically incorporated at levels in the range from about 0.5% to about 25%, preferably from about 1% to about 10% by weight of composition while the preformed organic peroxyacids themselves are typically incorporated at levels in the range from 0.5% to 25% by weight, more preferably from 1% to 10% by weight of composition.
• Bleach catalysts preferred for use herein include the manganese triazacyclononane and related complexes (US-A-4246612, US-A-5227084); Co, Cu, Mn and Fe bispyridylamine and related complexes (US-A-5114611); and pentamine acetate cobalt(lll) and related complexes(US-A-4810410).
• suitable components herein include organic polymers having dispersant, anti-redeposition, soil release or other detergency properties invention in levels of from about 0.1% to about 30%, preferably from about 0.5% to about 15%, most preferably from about 1% to about 10% by weight of composition.
• Preferred anti- redeposition polymers herein include acrylic acid containing polymers such as Sokalan PA30, PA20, PA15, PA10 and Sokalan CP10 (BASF GmbH), Acusol 45N, 480N, 460N (Rohm and Haas), acrylic acid/maleic acid copolymers such as Sokalan CP5 and acrylic/methacrylic copolymers.
• Preferred soil release polymers herein include alkyl and hydroxyalkyl celluloses (US-A-4,000,093), polyoxyethylenes, polyoxypropylenes and copolymers thereof, and nonionic and anionic polymers based on terephthalate esters of ethylene glycol, propylene glycol and mixtures thereof.
• Heavy metal seouestrants and crystal growth inhibitors are suitable for use herein in levels generally from about 0.005% to about 20%, preferably from about 0.1% to about 10%, more preferably from about 0.25% to about 7.5% and most preferably from about 0.5% to about 5% by weight of composition, for example diethylenetriamine penta (methylene phosphonate), ethylenediamine tetra(methylene phosphonate) hexamethylenediamine tetra(methylene phosphonate), ethylene diphosphonate, hydroxy-ethylene-1 ,1-diphosphonate, nitrilotriacetate, ethylenediaminotetracetate, ethylenediamine-N,N'-disuccinate in their salt and free acid forms.
• diethylenetriamine penta methylene phosphonate
• ethylene diphosphonate hydroxy-ethylene-1
• compositions herein can contain a corrosion inhibitor such as organic silver coating agents in levels of from about 0.05% to about 10%, preferably from about 0.1% to about 5% by weight of composition (especially paraffins such as Winog 70 sold by Wintershall, Salzbergen, Germany), nitrogen-containing corrosion inhibitor compounds (for example benzotriazole and benzimadazole - see GB-A-1137741) and Mn(ll) compounds, particularly Mn(ll) salts of organic ligands in levels of from about 0.005% to about 5%, preferably from about 0.01% to about 1%, more preferably from about 0.02% to about 0.4% by weight of the composition.
• a corrosion inhibitor such as organic silver coating agents in levels of from about 0.05% to about 10%, preferably from about 0.1% to about 5% by weight of composition (especially paraffins such as Winog 70 sold by Wintershall, Salzbergen, Germany), nitrogen-containing corrosion inhibitor compounds (for example benzotriazole and benzimadazole - see GB-A-113774
• Suitable components herein include colourants, water-soluble bismuth compounds such as bismuth acetate and bismuth citrate at levels of from about 0.01% to about 5%, enzyme stabilizers such as calcium ion, boric acid, propylene glycol and chlorine bleach scavengers at levels of from about 0.01% to about 6%, lime soap dispersants (see WO-A-93/08877), suds suppressors (see WO-93/08876 and EP-A-0705324), polymeric dye transfer inhibiting agents, optical brighteners, perfumes, fillers and clay and cationic fabric softeners.
• enzyme stabilizers such as calcium ion, boric acid, propylene glycol and chlorine bleach scavengers at levels of from about 0.01% to about 6%
• lime soap dispersants see WO-A-93/08877
• suds suppressors see WO-93/08876 and EP-A-0705324
• polymeric dye transfer inhibiting agents such as optical bright
• the detergent tablets herein are preferably formulated to have a not unduly high pH, preferably a pH in 1% solution in distilled water of from about 8.0 to about 12.5, more preferably from about 9.0 to about 11.8, most preferably from about 9.5 to about 11.5.
• the tablet will be the tablets described in the co-pending European application No. 9815525.2 filed 17 July 1998.
• Such tablets are multi-phase detergent tablets for use in a washing machine, the tablet comprising: a) a slower dissolving phase in the form of a shaped body having at least one mould therein (Section 1); and b) a second rapid dissolving phase in the form of a particulate solid compressed within said mould (Section 2), comprising the pectate lyase enzyme of the present invention.
• the first phase is a compressed shaped body prepared at an applied compression pressure of at least about 350 kg/cm 2 (3.43 kN/cm 2 ), preferably from about 400 to about 2000, especially from about 600 to about 1200 kg/cm 2 (compression pressure herein is the applied force divided by the cross-sectional area of the tablet in a plane transverse to the applied force - in effect, the transverse cross-sectional area of the die of the rotary press).
• the particulate solid of the second phase (which terminology is intended to include the possibility of multiple 'second' phases, sometimes referred to herein as 'optional subsequent phases') be compressed into said mould at an applied compression pressure less than that applied to the first phase and preferably at a compression pressure of less than about 350 kg/cm 2 , preferably in the range from about 40 kg/cm 2 to about 300 kg/cm 2 and more preferably from about 70 to about 270 kg/cm 2 , such tablets being preferred herein from the viewpoint of providing optimum tablet integrity and strength (measured for example by the Child Bite Strength [CBS] test) and product dissolution characteristics.
• CBS Child Bite Strength
• the tablets of the invention preferably have a CBS of at least 10kg, preferably greater than 12kg, more preferably greater than 14kg, CBS being measured per the US Consumer Product Safety Commission Test Specification.
• the compression pressures applied to the first and second phases will generally be in a ratio of at least about 2:1 , preferably at least about 4:1.
• a multiphase detergent tablet for use in a washing machine, the tablet comprising: a) a first slow dissolving phase in the form of a compressed shaped body having at least one mould therein, the shaped body being prepared at a compression pressure of at least about 350 kg/cm 2 ; and b) a second phase in the form of a particulate solid compressed within said mould, the second phase being compressed at a pressure of less than about 350 kg/cm 2 , comprising the pectate lyase enzyme of the present invention
• the second phase is in the form of a compressed or shaped body adhesively contained, for example by physical or chemical adhesion, within the at least one mould of the first body.
• the first and second phases are in a relatively high weight ratio to one another, for example at least about 6:1, preferably at least about 10:1; also that the tablet composition contain one or more detergent actives (for example enzymes, bleaches, bleach activators, bleach catalysts, surfactants, chelating agents etc) which is predominantly concentrated in the second phase, for example, at least about 50%, preferably at least about 60%, especially about 80% by weight of the active (based on the total weight of the active in tablet) is in the second phase of the tablet.
• detergent actives for example enzymes, bleaches, bleach activators, bleach catalysts, surfactants, chelating agents etc
• the preferred active is the pectate lyase enzyme.
• such compositions are optimum for tablet strength, dissolution, cleaning, and pH regulation characteristics providing, for example, tablet compositions capable of dissolving in the wash liquor so as to deliver at least 50%, preferably at least 60%, and more preferably at least 80% by weight of the pectate lyase to the wash liquor within 10, 5, 4 or even 3 minutes of the start of the wash process.
• a multiphase detergent tablet for use in a washing machine, the tablet comprising: a) slow dissolving first phase in the form of a shaped body having at least one mould therein (Section 1), and b) a rapid dissolving second phase containing pectate lyase and in the form of a particulate solid compressed within said mould (Section 2), and wherein section 2 of the tablet comprises at 70%, preferably at least 85%, more preferably at least 95% by weight of the pectate lyase which is delivered to the wash within the first 10 minutes, preferably within the first 5 minutes, and more preferably within the first 3 minutes of the wash process.
• Detergent tablets can be prepared simply by mixing the solid ingredients together and compressing the mixture in a conventional tablet press as used, for example, in the pharmaceutical industry.
• the principal ingredients in particular gelling surfactants, are used in particulate form.
• Any liquid ingredients, for example surfactant or suds suppressor, can be incorporated in a conventional manner into the solid particulate ingredients.
• the ingredients such as builder and surfactant can be spray-dried in a conventional manner and then compacted at a suitable pressure.
• the tablets according to the invention are compressed using a force of less than 100000N, more preferably of less than 50000N, even more preferably of less than 5000N and most preferably of less than 3000 N.
• the most preferred embodiment is a tablet suitable for laundry compressed using a force of less than 2500N, but tablets for auto dish washing may also be considered for example, whereby such auto dish washing tablets are usually more compressed than laundry tablets.
• the particulate material used for making the tablet of this invention can be made by any particulation or granulation process.
• An example of such a process is spray drying (in a co-current or counter current spray drying tower) which typically gives low bulk densities 600g/l or lower.
• Particulate materials of higher density can be prepared by granulation and densification in a high shear batch mixer/granulator or by a continuous granulation and densification process (e.g. using Lodige® CB and/or Lodige® KM mixers).
• Other suitable processes include fluid bed processes, compaction processes (e.g. roll compaction), extrusion, as well as any particulate material made by any chemical process like flocculation, crystallisation sentering, etc.
• Individual particles can also be any other particle, granule, sphere or grain.
• the components of the particulate material may be mixed together by any conventional means. Batch is suitable in, for example, a concrete mixer, Nauta mixer, ribbon mixer or any other. Alternatively the mixing process may be carried out continuously by metering each component by weight on to a moving belt, and blending them in one or more drum(s) or mixer(s).
• Non-gelling binder can be sprayed on to the mix of some, or all of, the components of the particulate material.
• Other liquid ingredients may also be sprayed on to the mix of components either separately or premixed. For example perfume and slurries of optical brighteners may be sprayed.
• a finely divided flow aid dustting agent such as zeolites, carbonates, silicas
• the tablets may be manufactured by using any compacting process, such as tabletting, briquetting, or extrusion, preferably tabletting. Suitable equipment includes a standard single stroke or a rotary press (such as Courtoy®, Korch®, Manesty®, or Bonals®).
• the tablets prepared according to this invention preferably have a diameter of between 20mm and 60mm, preferably of at least 35 and up to 55 mm, and a weight between 25 and 100 g.
• the ratio of height to diameter (or width) of the tablets is preferably greater than 1 :3, more preferably greater than 1 :2.
• the compaction pressure used for preparing these tablets need not exceed 100000 kN/m 2 , preferably not exceed 30000 kN/m 2 , more preferably not exceed 5000 kN/m 2 , even more preferably not exceed 3000kN/m 2 and most preferably not exceed 1000kN/m 2 .
• the tablet has a density of at least 0.9 g/cc, more preferably of at least 1.0 g/cc, and preferably of less than 2.0 g/cc, more preferably of less than 1.5 g/cc, even more preferably of less than 1.25 g/cc and most preferably of less than 1.1 g/cc.
• Multi layered tablets are typically formed in rotating presses by placing the matrices of each layer, one after the other in matrix force feeding flasks. As the process continues, the matrix layers are then pressed together in the pre- compression and compression stages stations to form the multilayer layer tablet. With some rotating presses it is also possible to compress the first feed layer before compressing the whole tablet.
• a highly soluble compound having a cohesive effect is integrated to the tablet of the invention, whereby this compound is also a hydrotrope compound.
• Such hydrotrope compound may be generally used to favour surfactant dissolution by avoiding gelling, so that they may be for example advantageously comprised in a softer faster dissolving layer which also contains the pectate lyase.
• a specific compound is defined as being hydrotrope as follows (see S.E. Friberg and M. Chiu, J. Dispersion Science and Technology, 9(5&6), pages 443 to 457, (1988-1989)):
• a solution is prepared comprising 25% by weight of the specific compound and 75% by weight of water.
• Octanoic Acid is thereafter added to the solution in a proportion of 1.6 times the weight of the specific compound in solution, the solution being at a temperature of 20°Celsius.
• the solution is mixed in a Sotax beaker with a stirrer with a marine propeller, the propeller being situated at about 5mm above the bottom of the beaker, the mixer being set at a rotation speed of 200 rounds per minute.
• the specific compound is hydrotrope if the the Octanoic Acid is completely solubilised, i.e . if the solution comprises only one phase, the phase being a liquid phase. It should be noted that in a preferred embodiment of the invention, the hydrotrope compound is a flowable material made of solid particles at operating conditions between 15 and 60° Celsius.
• Hydrotrope compounds include the compounds listed thereafter:
• Compounds of interest also include:
• Anionic hydrotropes such as alkali metal aryl sulfonates. This includes alkali metal salts of benzoic acid, salicylic acid, bezenesulfonic acid and its many derivatives, naphthoic acid and various hydroaromatic acids.
• dialkyl benzene sulfonic acid such as salts of di- isopropyl benzene sulfonic acid, ethyl methyl benzene sulfonic acid, alkyl benzene sulfonic acid with an alkyl chain length with 3 to 10, (pref. 4 to 9), linear or branched alkyl sulfonates with an alkyl chain with 1 to 18 carbons.
• Solvent hydrotropes such as alkoxylated glycerines and alkoxylated glycerides, esters slakoxylated glycerines, alkoxylated fatty acids, esters of glycerin, polyglycerol esters.
• Preferred alkoxylated glycerines have the following structure: R
• R represents H, CH 3 or
• Preferred alkoxylated glycerides have the following struture
• R is H or a C1-C10 alkyl group or is a hydrophilic functional group
• R1 is H a lower alkyl group or an aromatic group
• R2 is H or a cyclic alkyl or aromatic group.
• the polymer typically has a molecular weight of between about 1000 and
• Such compound would further increase the dissolution rate of the tablet, as a hydrotrope compound facilitates dissolution of surfactants, for example.
• a hydrotrope compound facilitates dissolution of surfactants, for example.
• Such a compound could be formed from a mixture or from a single compound.
• the solidity of the tablet according to the invention may be further improved by making a coated tablet, the coating covering a non-coated tablet according to the invention and containing the pectate lyase enzyme, thereby further improving the mechanical characteristics of the tablet while allowing rapid dissolution of the pectate lyase enzyme.
• the tablets may be coated so that the tablet does not absorb moisture, or absorbs moisture at only a very slow rate.
• the coating is also strong so that moderate mechanical shocks to which the tablets are subjected during handling, packing and shipping result in no more than very low levels of breakage or attrition.
• the coating is preferably brittle so that the tablet breaks up when subjected to stronger mechanical shock.
• the coating material is dissolved under alkaline conditions, or is readily emulsified by surfactants to allow release of the Pectate Lyase. This also contributes to avoiding the problem of visible residue in the window of a front-loading washing machine during the wash cycle, and also avoids deposition of undissoived particles or lumps of coating material on the laundry load.
• Water solubility is measured following the test protocol of ASTM E1148-87 entitled, "Standard Test Method for Measurements of Aqueous Solubility".
• Suitable coating materials that can be used in combination with pectate lyase are dicarboxylic acids.
• Particularly suitable dicarboxylic acids are selected from the group consisting of oxalic acid, malonic acid, succinic acid, glutaric acid, adipic acid, pimelic acid, suberic acid, azelaic acid, sebacic acid, undecanedioic acid, dodecanedioic acid, tridecanedioic acid and mixtures thereof.
• the coating material has a melting point preferably of from 40 °C to 200 °C.
• the coating can be applied in a number of ways. However, the preferred method when pectate lyase is contained in the coating is to coat with a solution of the material. In this method, the coating is applied as a solution, the solvent being dried to leave a coherent coating.
• the substantially insoluble material can be applied to the tablet by, for example, spraying or dipping. Clearly substantially insoluble materials having a melting point below 40 °C are not sufficiently solid at ambient temperatures and it has been found that materials having a melting point above about 200 °C are not practicable to use. Preferably, the materials melt in the range from 60 °C to 160 °C, more preferably from 70 °C to 120 °C.
• melting point is meant the temperature at which the material when heated slowly in, for example, a capillary tube becomes a clear liquid.
• a coating of any desired thickness can be applied according to the present invention.
• the coating forms from 1% to 10%, preferably from 1.5% to 5%, of the tablet weight.
• the tablet coatings of the present invention are very hard, provide extra strength to the tablet, and allow for early release of the pectate lyase.
• the fracture of the coating in the wash is improved by adding a disintegrant in the coating.
• This disintegrant will swell once in contact with water and break the coating in small pieces. This will improve the dissolution of the coating in the wash solution.
• the disintegrant is suspended in the coating melt at a level of up to 30%, preferably between 5% and 20%, most preferably between 5 and 10% by weight. Possible disintegrants are described in Handbook of Pharmaceutical Excipients (1986).
• Suitable disintegrants include starch: natural, modified or pregelatinized starch, sodium starch gluconate; gum: agar gum, guar gum, locust bean gum, karaya gum, pectin gum, tragacanth gum; croscarmylose Sodium, crospovidone, cellulose, carboxymethyl cellulose, algenic acid and its salts including sodium alginate, silicone dioxide, clay, polyvinylpyrrolidone, soy polysacharides, ion exchange resins and mixtures thereof.
• the layer may be considered as a tablet itself.
• the used compacting force may be adjusted to not affect the tensile strength, and the disintegration time in the washing machine. This process may be used to prepare homogenous or layered tablets of any size or shape.
• the tensile strength corresponds to the diametrical fracture stress (DFS) which is a way to express the strength of a tablet or layer, and is determined by the following equation :
• Tensile strength 2 F/ ⁇ Dt
• F the maximum force (Newton) to cause tensile failure (fracture) measured by a VK 200 tablet hardness tester supplied by Van Kell industries, Inc.
• D the diameter of the tablet or layer, and t the thickness of the tablet or layer. For a non round tablet, ⁇ D may simply be replaced by the perimeter of the tablet.
• a tablet having a diametral fracture stress of less than 20 kPa is considered to be fragile and is likely to result in some broken tablets being delivered to the consumer.
• a diametral fracture stress of at least 25 kPa is preferred. This applies similarly to non cylindrical tablets, to define the tensile strength, whereby the cross section normal to the height of the tablet is non round, and whereby the force is applied along a direction perpendicular to the direction of the height of the tablet and normal to the side of the tablet, the side being perpendicular to the non round cross section.
• the tablets further comprises an effervescent.
• Effervescency as defined herein means the evolution of bubbles of gas from a liquid, as the result of a chemical reaction between a soluble acid source and an alkali metal carbonate, to produce carbon dioxide gas, i.e. CQ QOJ + 3NaHCO3 • » Na ⁇ C ⁇ HsO + 3CO2 + 3H 2 O
• acid and carbonate sources and other effervescent systems may be found in : (Pharmaceutical Dosage Forms : Tablets Volume 1 Page 287 to 291).
• An effervescent may be added to the tablet mix in addition to the detergent ingredients.
• the addition of this effervescent to the detergent tablet improves the disintegration time of the tablet.
• the amount will preferably be between 5 and 20 % and most preferably between 10 and 20% by weight of the tablet.
• the effervescent should be added as an agglomerate of the different particles or as a compact, and not as separated particles.
• the tablet Due to the gas created by the effervescency in the tablet, the tablet can have a higher D.F.S. and still have the same disintegration time as a tablet without effervescency.
• the D.F.S. of the tablet with effervescency is kept the same as a tablet without, the disintegration of the tablet with effervescency will be faster.
• dissolution aid could be provided by using compounds such as sodium acetate or urea.
• suitable dissolution aid may also be found in Pharmaceutical Dosage Forms: Tablets, Volume 1 , Second edition, Edited by H.A. Lieberman et all, ISBN 0-8247-8044-2.
• Surfactant are comprised in the tablet according to the invention. Suitable surfactants are described herein above. Also suitable for the present tablet are builders, bleaching agents, enzymes and enzymes herein above described
• Non gelling binders can be integrated to the particles forming the tablet in order to further facilitate dissolution.
• suitable non-gelling binders include synthetic organic polymers such as polyethylene glycols, polyvinylpyrrolidones, polyacrylates and water-soluble acrylate copolymers.
• binders classification Acacia, Alginic Acid, Carbomer, Carboxymethylcellulose sodium, Dextrin, Ethylcellulose, Gelatin, Guar gum, Hydrogenated vegetable oil type I, Hydroxyethyl cellulose, Hydroxypropyl methylcellulose, Liquid glucose, Magnesium aluminum silicate, Maltodextrin, Methylcellulose, polymethacrylates, povidone, sodium alginate, starch and zein.
• binders also have an active cleaning function in the laundry wash such as cationic polymers, i.e. ethoxylated hexamethylene diamine quaternary compounds, bishexamethylene triamines, or others such as pentaamines, ethoxylated polyethylene amines, maleic acrylic polymers.
• cationic polymers i.e. ethoxylated hexamethylene diamine quaternary compounds, bishexamethylene triamines, or others such as pentaamines, ethoxylated polyethylene amines, maleic acrylic polymers.
• Non-gelling binder materials are preferably sprayed on and hence have an appropriate melting point temperature below 90°C, preferably below 70°C and even more preferably below 50°C so as not to damage or degrade the other active ingredients in the matrix.
• non-aqueous liquid binders i.e. not in aqueous solution
• they may also be solid binders incorporated into the matrix by dry addition but which have binding properties within the tablet.
• Non-gelling binder materials are preferably used in an amount within the range from 0.1 to 15% of the composition, more preferably below 5% and especially if it is a non laundry active material below 2% by weight of the tablet.
• gelling binders such as nonionic surfactants are avoided in their liquid or molten form.
• Nonionic surfactants and other gelling binders are not excluded from the compositions, but it is preferred that they be processed into the detergent tablets as components of particulate materials, and not as liquids.
• An essential element of the detergent tablets of the present invention is a pectate lyase enzyme.
• Pectate lyase is classified within the classification of enzymes provided by the Enzyme Nomenclature (1992) as EC 4.2.2.2. Said enzyme is known to split the ⁇ -1 ,4,glucoside bond of galacturonic acid found in pectin substances, creating a double bond between C4 and C5 and is substantially free for other pectin degrading activities, i.e having less than 25%, preferably less than 15%, more preferably less than 5% by weight of the enzyme compound of other pectin degrading enzyme activities.
• Pectate lyases have been cloned from different bacterial genera such as Erwinia, Pseudomonas, Klebsiella and Xanthomonas, Streptomyces, Penicillium, Bace ⁇ odes, Thermomonospora, Fusarium, and Aspergillus. Also from Bacillus subtilis (Nasser et al. (1993) FEBS 335:319-326) and Bacillus sp. YA-14 (Kim et al. (1994) Biosci. Biotech. Biochem. 58:947-949) cloning of a pectate lyase has been described.
• pectate lyases for use in the present invention are the protopectinases having an optimum reaction pH of 7.0 or higher when polygalacturonic acid is used as a substrate such as described in WO98/45393 and the pectic acid lyase having the amino acid sequence SEQ no 1 of EP 870 843 or having such amino acid sequence with one or more amino acid being deleted, added or substituted.
• a pectate lyase comprising a first amino acid sequence consisting of seven (7) amino acid residues having the following sequence: Asn Leu Asn Ser Arg Val Pro (NLNSRVP);
• a pectate lyase which is : i) a polypeptide produced by Bacillus agaradhaerens, NCIMB 40482 or
• DSM 8721 or by a Bacillus species having a 16S rDNA sequence homology to Bacillus agaradhaerens, DSM 8721 , of at least 99%, or ii) a polypeptide comprising an amino acid sequence as shown in positions
• Bacillus species having a 16S rDNA sequence homology to Bacillus licheniformis, ATCC 14580, of at least 99%, or ii) a polypeptide comprising an amino acid sequence as shown in positions
• a pectate lyase which is : i) a polypeptide produced by a Bacillus species having the 16S rDNA sequence of SEQ ID NO: 14 or by a Bacillus species having a 16S rDNA sequence homology to SEQ ID NO:14 higher than 97.3%; or ii) a polypeptide comprising an amino acid sequence as shown in positions
• a pectate lyase which is : i) a polypeptide produced by the species Bacillus halodurans, or ii) a polypeptide comprising an amino acid sequence as shown in positions 42-348 of SEQ ID NO:8 of PCT/DK98/00515, or iii) an analogue of the polypeptide defined in i) or ii) which is at least 45% homologous with said polypeptide, or iv) is derived from said polypeptide by substitution, deletion or addition of one or several amino acids, provided that the arginine in position 240, and optionally also the arginine in position 245, is conserved and the derived polypeptide is at least 40% homologous with said polypeptide, or v) is immunologically reactive with a polyclonal antibody raised against said polypeptide in purified form, - A pectate lyase which is i) a polypeptide produced by a Bacillus species having the 16S rDNA
• an analogue of the polypeptide defined in i) or which is at least 45% homologous with said polypeptide, or iv) is derived from said polypeptide by substitution, deletion or addition of one or several amino acids, provided that the arginine in position 227, and optionally also the arginine in position 232, is conserved and the derived polypeptide is at least 41% homologous with said polypeptide, or v) is immunologically reactive with a polyclonal antibody raised against said polypeptide in purified form.
• pectate lyase enzyme described in the international co- pending application PCT/DK98/00514, first filed in Denmark on November 24, 1997 and which is :
• D a polypeptide produced by Bacillus licheniformis, ATCC 14580, or ii) a polypeptide comprising an amino acid sequence as shown in positions 28-221 of SEQ ID NO:4 of PCT/DK98/00514, or ⁇ i) an analogue of the polypeptide defined in i) or ii) which is at least 60% homologous with said polypeptide, or iv) is derived from said polypeptide by substitution, deletion or addition of one or several amino acids, provided that the lysines in positions 133 and 155 and the arginine in position 158 are conserved and the derived polypeptide is at least 66% homologous with positions 60-158 of SEQ ID NO:4 of PCT/DK98/00514, or ) is immunologically reactive with a polyclonal antibody raised against said polypeptide in purified form.
• More preferred pectate lyases for the purpose of the present invention are those having optimum activity at pH's >7.0 and derived from Streptomyces fradiae, Streptomyces nitrosporeus, Erwinia carotovora, Bacillus spheroides, Thermomonospora fusca, Pseudomonas solanacearum, Bacteroides thetaiotaomicron, Fusarium solani, Xanthomonas campestris, Bacillus agaradhaerens, and/or Bacillus licheniformis.
• pectate lyase for the purpose of the present invention is the Pectate lyase from Bacillus agaradhaerens, NCIMB 40482 or DSM 8721.
• the pectate lyase is incorporated into the tablet of the invention preferably at a level of from 0.0001% to 2%, more preferably from 0.0005% to 0.1%, most preferred from 0.001% to 0.02% pure enzyme by weight of the composition.
• a level of from 0.0001% to 2%, more preferably from 0.0005% to 0.1%, most preferred from 0.001% to 0.02% pure enzyme by weight of the composition Preferably more than 70%, more preferably more than 85%, most preferably more than 95% of the total amount of the pectate lyase enzyme will be comprised in section 2 of the detergent tablet of the present invention.
• the pectate lyase of the invention in addition to the enzyme core comprising the catalytically domain, may also contain a cellulose binding domain (CBD), the cellulose binding domain and enzyme core (the catalytically active domain) of the enzyme being operably linked.
• the cellulose binding domain (CBD) may exist as an integral part of the encoded enzyme, or a CBD from another origin may be introduced into the enzyme thus creating an enzyme hybrid.
• CBD cellulose-binding domain
• the term "cellulose-binding domain” is intended to be understood as defined by Peter Tomme et al. "Cellulose-Binding Domains: Classification and Properties" in "Enzymatic Degradation of Insoluble Carbohydrates", John N. Saddler and Michael H.
• CBDs are found in various enzymes such as cellulases, xylanases, mannanases, arabinofuranosidases, acetyl esterases and chitinases. CBDs have also been found in algae, e.g. the red alga Porphyra purpurea as a non-hydrolytic polysaccharide-binding protein, see Tomme et al., op.cit.
• Enzyme hybrids are known in the art, see e.g. WO 90/00609 and WO 95/16782, and may be prepared by transforming into a host cell a DNA construct comprising at least a fragment of DNA encoding the cellulose- binding domain ligated, with or without a linker, to a DNA sequence encoding the pectate lyase enzyme and growing the host cell to express the fused gene. Enzyme hybrids may be described by the following formula:
• CBD is the N-terminal or the C-terminal region of an amino acid sequence corresponding to at least the cellulose binding domain
• MR is the middle region (the linker), and may be a bond, or a short linking group preferably of from about 2 to about 100 carbon atoms, more preferably of from 2 to 40 carbon atoms; or is preferably from about 2 to about 100 amino acids, more preferably of from 2 to 40 amino acids
• X is an N-terminal or C-terminal region of the pectate lyase of the invention.
• the above-mentioned enzymes may be of any suitable origin, such as vegetable, animal, bacterial, fungal and yeast origin. Origin can further be mesophilic or extremophilic (psychrophilic, psychrotrophic, thermophilic, barophilic, alkalophilic, acidophilic, halophilic, etc.). Purified or non-purified forms of these enzymes may be used.
• the variants may be designed such that the compatibility of the enzyme to commonly encountered ingredients of such compositions is increased.
• the variant may be designed such that the optimal pH, bleach or chelant stability, catalytic activity and the like, of the enzyme variant is tailored to suit the particular cleaning application.
• the isoelectric point of such enzymes may be modified by the substitution of some charged amino acids, e.g. an increase in isoelectric point may help to improve compatibility with anionic surfactants.
• the stability of the enzymes may be further enhanced by the creation of e.g. additional salt bridges and enforcing metal binding sites to increase chelant stability.
• the detergent tablets of the present invention will comprise a buffering agent together with the pectate lyase enzyme.
• buffering agents might be required to generate the optimum pH for activity of the pectate lyase. Any standard buffering agent can be used. Preferred are those having optimum buffer capacity at the pH where the pectate lyase shows optimum activity.
• Examples include NaH2PO4, NaHCO3, Na2CO3 and Citric Acid, tris(Hydroxymethyl)aminomethane (Trizma (TM) from Sigma), triethanol amine, NN,bis(2-Hydroxyethyl)glycine, N-tris(Hydroxymethyl)methyl-3-aminopropane- sulfonic acid and/or mixtures thereof.
• buffering agent is typically present at 5% or less by weight of the rapid, pectate lyase containing-dissolving phase.”
• compositions of the invention may be used in essentially any washing or cleaning methods, including soaking methods, pretreatment methods and methods with rinsing steps for which a separate rinse aid composition may be added.
• the process of the invention is conveniently carried out in the course of the cleaning process.
• the method of cleaning is preferably carried out at 5°C to 95°C, especially between 10°C and 60°C.
• the pH of the treatment solution is preferably from 7 to 12.
• a preferred machine dishwashing method comprises treating soiled articles selected from crockery, glassware, silverware, metallic items, cutlery and mixtures thereof, with an aqueous liquid having dissolved or dispensed therein an effective amount of a the herein described compositions.
• an effective amount is meant from 8g to 60g of product dissolved or dispersed in a wash solution of volume from 3 to 10 litres, as are typical product dosages and wash solution volumes commonly employed in conventional machine dishwashing methods.
• the detergent tablets are from 15g to 40g in weight, more preferably from 20g to 35g in weight.
• Machine laundry methods herein typically comprise treating soiled laundry with an aqueous wash solution in a washing machine having dissolved or dispensed therein an effective amount of the herein described compositions.
• an effective amount is meant from 20g to 300g of product dissolved or dispersed in a wash solution of volume from 5 to 65 litres, as are typical product dosages and wash solution volumes commonly employed in conventional machine laundry methods.
• Amylase Amylolytic enzyme sold under the tradename
• Pectate Lyase Pectate Lyase from Bacillus agaradhaerens
• the following illustrates examples detergent tablets of the present invention suitable for use in a dishwashing machine.
• the tablet compositions are prepared as follows.
• the detergent active composition of phase 1 is prepared by admixing the granular and liquid components and is then passed into the die of a conventional rotary press.
• the press includes a punch suitably shaped for forming a mould.
• the cross-section of the die is approximately 30x38 mm.
• the composition is then subjected to to a compression force of 940 kg/cm 2 and the punch is then elevated exposing the first phase of the tablet containing the mould in its upper surface.
• the detergent active composition of phase 2 is prepared in similar manner and is passed into the die.
• the particulate active composition is then subjected to a compression force of 170 kg/cm 2 , the punch is elevated, and the multi-phase tablet ejected from the tablet press.
• the resulting tablets dissolve or disintegrate in a washing machine as described above within 12 minutes, phase 2 of the tablets dissolving within 5 minutes.
• the tablets display improved strength, especially on long-term storage, together with excellent dissolution characteristics
• Detergent powder of compositions l-IV was prepared as follows: all the particulate materials of base composition were mixed together in a mixing drum or spray drum to form a homogenous particulate mixture. During this mixing the spray-on of the binder system was carried out. After this stage, the matrix was separated in two different samples. The DIBS sticky hydrotope was added to only one of the samples and then processed independently in a Loedige KM 600 ® . The layer with DIBS was used for a harder bottom layer and the layer without DIBS was used for a softer top layer of a dual layer tablet. ⁇ ) Using a Bonals ® rotary press both matrices were filled in two independent force feeding flasks.
• the matrix with DIBS is consecutively filled first in the turret stations, followed by the second matrix (the without DIBS matrix). Both layers are compressed together in the pre-compression and compression stations to form a dual layer tablet with a harder bottom layer.
• the tablets have a rectangular cross section of 62.5 by 38.5 mm, a height of 20.5 mm and a weight of 48 gr. The height of the bottom layer corresponded to 25% of the total height of the tablet. If a round tablet is made of the bottom layer matrix with the same density as in the rectangular tablet (983 g/l), the tensile strength of the layer is 7.8 kPa.
• the top layer of the tablet has an equivalent tensile strength of 5.1 kPa.
• Elasticity measurements gave values of 1.8 J/kN for the top layer and 3.3 J/kN for the bottom layer.
• base particulate material composition for making laundry detergent tablets according to the invention whereby a harder layer may be more compressed than a softer layer, or whereby different compositions may be used or adapted for each layer.
• the enzymes levels are expressed by pure enzyme by weight of the total composition and unless otherwise specified, the detergent ingredients are expressed by weight of the total compositions.
• Binder Spray-on-system 1 1.3 2.5 - -
• Anionic agglomerates 1 comprise of 40% anionic surfactant, 27% zeolite and 33% carbonate.
• Anionic agglomerates 2 comprise of 40% anionic surfactant, 28% zeolite and 32% carbonate.
• Nonionic agglomerate comprise 26% nonionic surfactant, 6% Lutensit K-HD 96,
• Cationic agglomerates comprise of 20% cationic surfactant, 56% zeolite and 24% sulphate.
• Layered silicate comprises of 95% SKS 6 and 5% silicate.
• Bleach activator agglomerates comprise of 81% TAED, 17% acrylic/maleic copolymer (acid form) and 2% water.
• Ethylene diamine N,N-disuccinic acid sodium salt/Sulphate particle comprise of
• Zinc phthalocyanine sulphonate encapsulates are 10% active.
• Suds suppressor comprises of 11.5% silicone oil (ex Dow Corning); 59% of zeolite and 29.5% of water.
• Binder spray-on system 1 comprises of 50% Lutensit K-HD 96 and 50% PEG
• Binder spray-on system 2 comprises of 0.5 parts of Lutensit K-HD 96 and 2.5 parts of PEGs.
• Perfume encapsulates comprise 50% perfume and 50% starch.
• Polymer particle comprises 36%, 54% zeolite and 10% water
• the Nonionic spray-on system comprises of 67% C12-C15 AE5 (alcohol with an average of 5 ethoxy groups per molecule), 24% N-methyl glucose amide and 9% water.
• Protease is selected from: proteolytic enzyme sold under the tradename Savinase, Alcalase, Durazym by Novo Nordisk A/S, Maxacal, Maxapem sold by Gist-Brocades and proteases described in patents WO91/06637 and/or WO95/10591 and/or EP 251 446 and/or mixutres thereof.
• Amylase is selected from: Amylolytic enzyme sold under the tradename Purafact Ox Am R described in WO 94/18314, WO96/05295 sold by Genencor; Termamyl ®, Fungamyl® and Duramyl®, all available from Novo Nordisk A/S and those described in WO95/26397(Sold under the tradename Natalase by Novo Nordisk A/S) and/or mixtures thereof.
• Lipase is selected from: Lipolytic enzyme sold under the tradename Lipolase,
• Pectate lyase from Bacillus agaradhaerens, NCIMB 40482 or DSM 8721.
• Cellulase is selected from: Cellulytic enzyme sold under the tradename

Landscapes

• Chemical & Material Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Engineering & Computer Science (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Oil, Petroleum & Natural Gas (AREA)
• Wood Science & Technology (AREA)
• Organic Chemistry (AREA)
• Detergent Compositions (AREA)
• Enzymes And Modification Thereof (AREA)

Applications Claiming Priority (1)

Publications (1)

Family

ID=22271988

Family Applications (1)

Country Status (5)

Families Citing this family (3)

Family Cites Families (4)

• 1999
  • 1999-01-14 EP EP99903093A patent/EP1141202A1/de not_active Withdrawn
  • 1999-01-14 WO PCT/US1999/000800 patent/WO2000042148A1/en not_active Application Discontinuation
  • 1999-01-14 JP JP2000593705A patent/JP2002534594A/ja not_active Abandoned
  • 1999-01-14 CA CA002357800A patent/CA2357800A1/en not_active Abandoned
  • 1999-01-14 AU AU23198/99A patent/AU2319899A/en not_active Abandoned

Non-Patent Citations (1)

Also Published As

Similar Documents

Legal Events